Literature DB >> 24388080

Extrapulmonary tuberculosis among adults: experience at Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa.

Alan S Karstaedt1.   

Abstract

BACKGROUND: Extrapulmonary tuberculosis (EPTB) occurs in 15 - 20% of immunocompetent and 20 - 70% of HIV-infected patients with tuberculosis. There are few recent incidence data for EPTB.
METHODS: Adults (N=2 963) with culture-proven EPTB seen over 2 years at Chris Hani Baragwanath Academic Hospital, the main referral hospital serving Soweto, Johannesburg, South Africa, were retrospectively studied for pattern and incidence.
RESULTS: The commonest sites of EPTB were the pleura (39.1%), lymph nodes (31.0%), blood (21.8%), meninges (7.3%), and peritoneum (2.9%). Disseminated tuberculosis occurred in 25.0%. The median age was 33 years (range 18 - 87 years). Males comprised 53.2% overall, with a female majority in the peritonitis group. For Soweto, the incidence of adult EPTB was 88.6/100 000 population, rising to 139.4/100 000 and 125.7/100 000 in the 25 - 34-year and 35 - 44-year age groups, respectively. There was no secondary peak in the elderly (17.9/100 000).
CONCLUSIONS: This retrospective cohort showed a high incidence of EPTB, most marked in the 25 - 44-year age group. Culture of extrapulmonary sites is of importance to confirm diagnosis of tuberculosis and to ensure antituberculosis drug susceptibility testing.

Entities:  

Mesh:

Year:  2013        PMID: 24388080     DOI: 10.7196/samj.6374

Source DB:  PubMed          Journal:  S Afr Med J


  8 in total

1.  Reduction in extrapulmonary tuberculosis in context of antiretroviral therapy scale-up in rural South Africa.

Authors:  J C Hoogendoorn; L Ranoto; N Muditambi; J Railton; M Maswanganyi; H E Struthers; J A McIntyre; R P H Peters
Journal:  Epidemiol Infect       Date:  2017-07-27       Impact factor: 4.434

2.  Patterns of Lymph Node Pathology; Fine Needle Aspiration Biopsy as an Evaluation Tool for Lymphadenopathy: A Retrospective Descriptive Study Conducted at the Largest Hospital in Africa.

Authors:  Denasha Lavanya Reddy; Willem Daniel Francois Venter; Sugeshnee Pather
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

3.  The determinants and impact of diagnostic delay in lymphoma in a TB and HIV endemic setting.

Authors:  Katherine Antel; Carly Levetan; Zainab Mohamed; Vernon J Louw; Jenna Oosthuizen; Gary Maartens; Estelle Verburgh
Journal:  BMC Cancer       Date:  2019-04-25       Impact factor: 4.430

4.  The use of real-time polymerase chain reaction and an adenosine deaminase assay for diagnosing pleural tuberculosis.

Authors:  Mulalo Molaudzi; Julitha Molepo
Journal:  Afr J Lab Med       Date:  2019-08-28

5.  Same-Day Tools, Including Xpert Ultra and IRISA-TB, for Rapid Diagnosis of Pleural Tuberculosis: a Prospective Observational Study.

Authors:  Richard Meldau; Philippa Randall; Anil Pooran; Jason Limberis; Edson Makambwa; Muhammed Dhansay; Aliasgar Esmail; Keertan Dheda
Journal:  J Clin Microbiol       Date:  2019-08-26       Impact factor: 5.948

6.  Economic evaluation of microbiological and host biomarker-based tests for the diagnosis of pleural tuberculosis in a high burden setting.

Authors:  Anil Pooran; Philippa Randall; Richard Meldau; Rebeng Maine; Aliasgar Esmail
Journal:  J Thorac Dis       Date:  2022-09       Impact factor: 3.005

7.  Machine learning reveals that Mycobacterium tuberculosis genotypes and anatomic disease site impacts drug resistance and disease transmission among patients with proven extra-pulmonary tuberculosis.

Authors:  Doctor B Sibandze; Beki T Magazi; Lesibana A Malinga; Nontuthuko E Maningi; Bong-Akee Shey; Jotam G Pasipanodya; Nontombi N Mbelle
Journal:  BMC Infect Dis       Date:  2020-07-31       Impact factor: 3.090

8.  Diagnosis and clinical outcomes of extrapulmonary tuberculosis in antiretroviral therapy programmes in low- and middle-income countries: a multicohort study.

Authors:  Kathrin Zürcher; Marie Ballif; Sasisopin Kiertiburanakul; Henri Chenal; Marcel Yotebieng; Beatriz Grinsztejn; Denna Michael; Timothy R Sterling; Kapella M Ngonyani; Anna M Mandalakas; Matthias Egger; April C Pettit; Lukas Fenner
Journal:  J Int AIDS Soc       Date:  2019-09       Impact factor: 5.396

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.